Baupost Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $14.5M | Hold |
|
|||||
|
2023
Q2 | $15.7M | Buy |
|
|||||
|
2023
Q1 | $26.5M | Buy |
|
|||||
|
2022
Q4 | $26.6M | Hold |
|
|||||
|
2022
Q3 | $30.7M | Hold |
|
|||||
|
2022
Q2 | $63.3M | Hold |
|
|||||
|
2022
Q1 | $75.5M | Sell |
|
|||||
|
2021
Q4 | $134M | Hold |
|
|||||
|
2021
Q3 | $152M | Hold |
|
|||||
|
2021
Q2 | $132M | Hold |
|
|||||
|
2021
Q1 | $122M | Sell |
|
|||||
|
2020
Q4 | $179M | Sell |
|
|||||
|
2020
Q3 | $129M | Hold |
|
|||||
|
2020
Q2 | $145M | Buy |
|
|||||
|
2020
Q1 | $70.7M | Hold |
|
|||||
|
2019
Q4 | $137M | Hold |
|
|||||
|
2019
Q3 | $117M | Buy |
|
|||||
|
2019
Q2 | $141M | Buy |
|
|||||
|
2019
Q1 | $254M | Buy |
|
|||||
|
2018
Q4 | $217M | Hold |
|
|||||
|
2018
Q3 | $259M | Hold |
|
|||||
|
2018
Q2 | $230M | Hold |
|
|||||
|
2018
Q1 | $244M | Buy |
|
|||||
|
2017
Q4 | $97M | Hold |
|
|||||
|
2017
Q3 | $88.7M | Hold |
|
|||||
|
2017
Q2 | $75M | Hold |
|
|||||
|
2017
Q1 | $110M | Hold |
|
|||||
|
2016
Q4 | $76.1M | Hold |
|
|||||
|
2016
Q3 | $115M | Hold |
|
|||||
|
2016
Q2 | $121M | Hold |
|
|||||
|
2016
Q1 | $102M | Hold |
|
|||||
|
2015
Q4 | $142M | Hold |
|
|||||
|
2015
Q3 | $169M | Buy |
|
|||||
|
2015
Q2 | $254M | Buy |
|
|||||
|
2015
Q1 | $193M | Buy |
|
|||||
|
2014
Q4 | $59.1M | Buy |
|